Identifying central symptom clusters and correlates among post-COVID-19 pulmonary fibrosis patients: a network analysis

Identifying central symptom clusters and correlates among post-COVID-19 pulmonary fibrosis patients: a network analysis

BackgroundPrevious studies have analyzed symptom clusters in patients with coronavirus disease 2019 (COVID-19); however, evidence regarding the core symptom clusters and their influencing factors in patients with post-COVID-19 pulmonary fibrosis (PCPF) remains unclear, affecting the precision of sym...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhen Yang, Zhiqin Xie, Zequan Wang, Linxia Yi, Shihan Chen, Yunyu Du, Xuemei Tao, Chao Xie, Li Zhou, Min Zhang, Chaozhu He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Medicine
Subjects:	COVID-19 pulmonary fibrosis lung diseases interstitial syndrome social network analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1538708/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Time trends in thermal burns incidence among Brazil, Russia, India, China, and South Africa (BRICS), an age-period-cohort analysis from the GBD 2019
by: Linxia Yi, et al.
Published: (2025-02-01)

Research advances of pericytes in renal interstitial fibrosis
by: Feng Yi-duo, et al.
Published: (2022-01-01)

Differential proteomics of interstitial fluid in lung tissue associated with the progression of pulmonary fibrosis in mice
by: Xi Lu, et al.
Published: (2025-04-01)

Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01)

Integrating CT radiomics and clinical data with machine learning to predict fibrosis progression in coalworker pneumoconiosis
by: Xiaobing Li, et al.
Published: (2025-07-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)

Research progress on the role of Hedgehog signaling pathway in renal interstitial fibrosis
by: ZHOU Lan-qi, et al.
Published: (2020-01-01)

Noninvasive grading of renal interstitial fibrosis and prediction of annual renal function loss in chronic kidney disease: the optimal solution of seven MR diffusion models
by: Guanjie Yuan, et al.
Published: (2025-12-01)

The role of macrophages in renal fibrosis and therapeutic prospects
by: Di Niu, et al.
Published: (2025-07-01)

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Expression and clinical significance of Sonic hedgehog in renal interstitial fibrosis of patients with diabetic kidney disease
by: HOU Shi-hui, et al.
Published: (2017-01-01)

Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis
by: Lijun Wang, et al.
Published: (2024-10-01)

“POSSIBLE” OR “PROBABLE”. THE NEW APPROACH IN IDIOPATHIC PULMONARY FIBROSIS DIAGNOSIS
by: D. V. Petrov, et al.
Published: (2018-08-01)

Chitosan oligosaccharide attenuates acute kidney injury and renal interstitial fibrosis induced by ischemia-reperfusion
by: Shulan Yin, et al.
Published: (2023-12-01)

Expression and clinical significance of Wnt4/β-catenin signaling pathway in glomerular diseases
by: WU Xiao-zhen, et al.
Published: (2019-01-01)

Inhibition of renal interstitial fibrosis by mulberry leaf alkaloids in rats with diabetic nephropathy
by: Feng Wu, et al.
Published: (2022-08-01)

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review
by: Maria Conti, et al.
Published: (2025-07-01)

Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait
by: Nicol Bernardinello, et al.
Published: (2025-06-01)

Exosomes secreted by ATF3/Nrf2-mediated ferroptotic renal tubular epithelial cells promote M1/M2 ratio imbalance inducing renal interstitial fibrosis following ischemia and reperfusion injury
by: Qiao Tang, et al.
Published: (2025-02-01)

Correction: Exosomes secreted by ATF3/Nrf2-mediated ferroptotic renal tubular epithelial cells promote M1/M2 ratio imbalance inducing renal interstitial fibrosis following ischemia and reperfusion injury
by: Qiao Tang, et al.
Published: (2025-07-01)

MicroRNAs as fibrosis markers in patients with hypersensitivity pneumonitis
by: G. S. Shepelkova, et al.
Published: (2024-04-01)

Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis
by: Negar Golchin, et al.
Published: (2025-08-01)

Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
by: Ignacio Español Montero, et al.
Published: (2025-06-01)

A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology
by: A. V. Teteneva, et al.
Published: (2021-10-01)

The mechanism of plasma exosome miR-15a-5p targeting the CF-modified protein IGF1R to regulate alveolar epithelial autophagy and influence pulmonary interstitial fibrosis
by: Yina Li, et al.
Published: (2025-12-01)

The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey
by: Yuko Kaneko, et al.
Published: (2025-04-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis
by: Yanisa Kluanwan, et al.
Published: (2025-05-01)

Frequency of imaging phenotypes of pulmonary interstitial fibrosis
by: Wallace T. Miller Jr, et al.
Published: (2025-05-01)

Dynamic regulation of proximal tubular autophagy from injury to repair after ischemic kidney damage
by: Yuhong Gong, et al.
Published: (2024-12-01)

Impact of Air Pollution on the Long-Term Decline of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease
by: Pablo Mariscal-Aguilar, et al.
Published: (2024-11-01)

TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway
by: Ruixiang Luo, et al.
Published: (2025-04-01)

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases
by: Erika M. Novoa-Bolivar, et al.
Published: (2024-10-01)

The role of lung cancer in mortality rate in chronic fibrosing idiopathic interstitial pneumonia
by: Beatriz Morales Chacón, et al.
Published: (2025-05-01)

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study
by: A. Denis, et al.
Published: (2025-05-01)

Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway
by: Huan Xu, et al.
Published: (2025-03-01)

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
by: Giacomo Sica, et al.
Published: (2025-01-01)

Xanthohumol ameliorates diabetic kidney disease through suppression of renal fibrosis by regulating SNHG10/miR-378b
by: Jian Hao, et al.
Published: (2025-05-01)

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points
by: Steven D. Nathan, MD, et al.
Published: (2025-06-01)